Our Company Products Innovation Responsibility Media Investors Careers Home Contact Sitemap Search Acquisition of Sigma-Aldrich Enhancement of position in attractive Life Science industry Merck KGaA, Darmstadt, Germany, and Sigma-Aldrich, one of the leading US-based life science and technology companies, today announced that they have entered into a definitive agreement under which Merck KGaA will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion) in cash, establishing one of the leading players in the $ 130 billion global life science industry. More information on the acquisition of Sigma-Aldrich Please Read Disclaimer We are a leading pharmaceutical and chemical company We are a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. We operate our businesses in four divisions: Biopharmaceuticals, Consumer Health (over-the-counter pharmaceuticals), Performance Materials (high-tech chemicals) and Life Science Tools. QUICKLINKS Annual Report 2013 Products Management Stock & Bond Info Global Job Search The Merck Way OUR BUSINESSES WEB SITES Biopharmaceuticals Over-the-counter pharmaceuticals High-tech chemicals Life science tools CORPORATE NEWS 2014/09/22 Merck KGaA to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Scien ... 2014/09/18 Merck KGaA on Track with Pharma Strategy; Pipeline Progress Announced All News Releases Legal Disclaimer Terms of Use Privacy Statement © Merck KGaA, Darmstadt, Germany Last Update 2014/09/25